Sulnox Group PLC

Share Issue/Capital Change • Sep 22, 2025

National Storage Mechanism | Additional information

RNS Number : 2281A

Sulnox Group PLC

22 September 2025

22 September 2025

Sulnox Group Plc

(the "Company" or "Sulnox")

Issue of Shares to Consultant

Total Voting Rights

The Company has issued a total of 13,157 new ordinary shares of 2 pence each ("Ordinary Shares") in settlement of invoices from a consultant (the "Consultancy Shares"), at a price of 57.00 pence per Ordinary Share in settlement of a liability of £7,500.00.

The price of the above issue has been calculated on the average share price for the period of time over which the services were delivered and the terms of the consultant's contract. 

Admission and Total Voting Rights

An application will be made to admit the Consultancy Shares for trading on the AQSE Growth Market, which is anticipated to occur on or around 26 September 2025 ("Admission").  The Consultancy Shares are being issued under the Company's existing share authorities.

On Admission, the Company will have 131,145,434 Ordinary Shares in issue, each with one voting right. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company is 131,145,434. This figure should be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

- Ends -

For further information please contact:

Sulnox Group plc Steven Cowin, CFO	Tel: 07624 491 821
Allenby Capital Limited (AQSE Corporate Adviser) Nick Harriss / John Depasquale (Corporate Finance) Guy McDougall (Equity Sales)	Tel: 020 3328 5656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXGRGDCGSDDGUD